$0.80
-0.02 (-2.44%)
DURECT Corp (NASDAQ:DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.
RSS Headlines
Fool UK